HC Wainwright & Co. Maintains Buy on Immunocore Holdings, Lowers Price Target to $80
Benzinga Newsdesk 3 hours ago
Analyst RatingsNewsPrice Target
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Immunocore Holdings (NASDAQ:IMCR) with a Buy and lowers the price target from $100 to $80.
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Immunocore Holdings (NASDAQ:IMCR) with a Buy and lowers the price target from $100 to $80.